(Q46902752)

English

Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer

scientific article published in April 2014

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit